Safety of vascular endothelial and hepatocyte growth factor gene therapy in patients with critical limb ischemia
{{output}}
The present clinical trial analyzed the safety of gene therapy using plasmidial constructs expressing vascular endothelial and hepatocyte growth factors in patients with critical limb ischemia. The study included 43 patients: 29 in the treatment group and 14 a... ...
